Trial intelligence / Profile preview

Kunbao Pill for menopausal syndrome

ChiCTR2300072875Phase 4Not yet recruiting

Sponsor
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Start
Jun 2023
Countries
1
01

Overview

Phase 4, randomised trial of Kunbao Pill in menopause (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: TCM syndrome integral table and Improved Kupperman Rating Scale in China. Planned start Jun 2023; status: not yet recruiting.

02

Drugs

Kunbao Pill
03

Conditions

menopause

Beyond the preview

Go deeper on ChiCTR2300072875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300072875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call